标题
Prevention of cardiotoxicity among survivors of childhood cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 83, Issue 3, Pages 455-465
出版商
Wiley
发表日期
2016-09-05
DOI
10.1111/bcp.13120
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors
- (2016) Steven E. Lipshultz et al. CANCER
- Molecular Mechanisms of the Cardiotoxicity of the Proteasomal-Targeted Drugs Bortezomib and Carfilzomib
- (2016) Brian B. Hasinoff et al. Cardiovascular Toxicology
- Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404
- (2016) Barbara L. Asselin et al. JOURNAL OF CLINICAL ONCOLOGY
- Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice
- (2016) Vikrant Vijay et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Cardiovascular Disease in Adult Survivors of Childhood Cancer
- (2015) Steven E. Lipshultz et al. Annual Review of Medicine
- The Concise Guide to PHARMACOLOGY 2015/16: Transporters
- (2015) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
- (2015) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Impact of dexrazoxane on doxorubicin-induced aneuploidy in somatic and germinal cells of male mice
- (2015) S. M. Attia et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group
- (2015) Eric J. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
- (2015) Christopher Southan et al. NUCLEIC ACIDS RESEARCH
- Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group
- (2015) Cindy L. Schwartz et al. PEDIATRIC BLOOD & CANCER
- Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia
- (2015) M Krajinovic et al. PHARMACOGENOMICS JOURNAL
- Cost-Effectiveness of Cardioprotective Effect of Dexrazoxane (Cardioxane®) in Advanced/Metastatic Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy in México
- (2015) JÁ Paladio-Hernández et al. VALUE IN HEALTH
- Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy
- (2014) Kasey Leger et al. PEDIATRIC BLOOD & CANCER
- Managing Chemotherapy-Related Cardiotoxicity in Survivors of Childhood Cancers
- (2014) Steven E. Lipshultz et al. PEDIATRIC DRUGS
- Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia
- (2013) Steven E. Lipshultz et al. CANCER
- Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
- (2013) Steven E. Lipshultz et al. CIRCULATION
- Treatment-related cardiotoxicity in survivors of childhood cancer
- (2013) Steven E. Lipshultz et al. Nature Reviews Clinical Oncology
- Ethnic group differences in cardiometabolic disease risk factors independent of body mass index among American youth
- (2013) Sarah E. Messiah et al. Obesity
- Increasing exercise in long-term survivors of pediatric cancer and their siblings: Should treatment be a family affair?
- (2013) Rudolf Steiner PEDIATRIC BLOOD & CANCER
- Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline-induced cardiotoxicity in children
- (2013) H. Visscher et al. PEDIATRIC BLOOD & CANCER
- Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: An analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study
- (2012) David C. Landy et al. AMERICAN HEART JOURNAL
- Detection and prevention of cardiac complications of cancer chemotherapy
- (2012) Jean-Jacques Monsuez Archives of Cardiovascular Diseases
- Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease
- (2012) S. H. Armenian et al. BLOOD
- Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
- (2012) David Ebb et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular Status of Childhood Cancer Survivors Exposed and Unexposed to Cardiotoxic Therapy
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Exercise capacity in long-term survivors of pediatric cancer: An analysis from the cardiac risk factors in childhood cancer survivors study
- (2012) Angela M. Miller et al. PEDIATRIC BLOOD & CANCER
- Cranial Irradiation as an Additional Risk Factor for Anthracycline Cardiotoxicity in Childhood Cancer Survivors: An Analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study
- (2012) David C. Landy et al. PEDIATRIC CARDIOLOGY
- Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
- (2012) S. E. Lipshultz et al. PEDIATRICS
- The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium
- (2011) Lynda M. Vrooman et al. EUROPEAN JOURNAL OF CANCER
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group
- (2011) Javier G. Blanco et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer
- (2011) Barry H. Trachtenberg et al. PEDIATRIC CARDIOLOGY
- Characteristics and Determinants of Adiposity in Pediatric Cancer Survivors
- (2010) T. L. Miller et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer
- (2010) Raoul C. Reulen JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiotoxicity After Childhood Cancer: Beginning With the End in Mind
- (2010) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
- (2010) Steven E Lipshultz et al. LANCET ONCOLOGY
- ‘Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985–2000)’
- (2010) M Schrappe et al. LEUKEMIA
- Diabetes Mellitus in Long-term Survivors of Childhood Cancer
- (2009) Lillian R. Meacham et al. ARCHIVES OF INTERNAL MEDICINE
- Predictors of inactive lifestyle among adult survivors of childhood cancer
- (2009) Kirsten K Ness et al. CANCER
- Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
- (2008) Javier G. Blanco et al. CANCER
- Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study
- (2008) A. C. Mertens et al. JNCI-Journal of the National Cancer Institute
- Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group
- (2008) S. M. Shankar et al. PEDIATRICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now